Remedium Capital Partners, LLC: APGE position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Remedium Capital Partners, LLC on APGE, newest first. How the timeline and the estimate are built.

Remedium Capital Partners, LLC held 586,691 APGE shares at 2026-06-30 per its 13F-HR filed 2026-08-07.

the latest 13F is the newest step

period ended2026-06-30
13F 586,691 shares
Change vs previous 13F +3,100 shares
17.24% of the 13F portfolio, value $77,871,496.
13F-HR 0002104501-26-000015 filed by Remedium Capital Partners, LLC
Filed 2026-08-07 (acceptance time not in the bulk data set), ingested 2026-10-06 09:57:27 UTC
Acceptance time not in the bulk data set (spec §4.2).
period ended2026-03-31
13F/A 583,591 shares
Change vs previous 13F 0 shares
17.47% of the 13F portfolio, value $49,120,854.
13F-HR/A 0002104501-26-000010 filed by Remedium Capital Partners, LLC
Filed 2026-05-19 (acceptance time not in the bulk data set), ingested 2026-10-06 09:58:43 UTC
Acceptance time not in the bulk data set (spec §4.2).
period ended2025-12-31
13F 583,591 shares
Change vs previous 13F not available
25.88% of the 13F portfolio, value $44,050,000.
13F-HR 0002104501-26-000004 filed by Remedium Capital Partners, LLC
Filed 2026-02-12 (acceptance time not in the bulk data set), ingested 2026-10-07 03:01:36 UTC
Acceptance time not in the bulk data set (spec §4.2).